ENTITY
CSL Ltd

CSL Ltd (CSL AU)

120
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bullishMSCI ACWI Index
21 Jun 2019 06:57

Global Equities Nearing Potential Resistance

we believe global equities remain in a state of purgatory and consolidation is likely to continue as several major indexes approach logical...

Logo
458 Views
Share
28 May 2019 12:01

Time to Dissect Aussie Growth Stocks

Growth stocks have again out-performed Value since the start of the year supported by declining bond yields and solid EPS growth. In our March...

Logo
603 Views
Share
06 Mar 2019 06:07

Aussie Equities Reporting Season Wrap: March 2019

Australia rallied strongly through a relatively solid reporting season, with the benchmark ASX 200 posting a strong 6% gain in the month. EPS was...

Logo
229 Views
Share
20 Feb 2019 07:43

Aussie Reporting Season Update: February 2019

The Banks remain under earnings pressure from several fronts, with weak credit growth, falling net interest margins and rising compliance costs...

Logo
527 Views
Share
05 Dec 2018 06:37

Aussie Equities 2019: On a Wing and a Prayer

We expect 2019 will be challenging. Offshore macro and Geopolitical issues emerged in 2018 to dash our expectations of a good year for the Aussie...

Logo
481 Views
Share
x